ADIAL PHARMACEUTICALS, INC.

ADIL

ADIAL PHARMACEUTICALS, INC.

ADIL

Insider Sentiment (TTM):

Last Purchase:2023-09-29Last Sale:2021-10-04Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:35,546Shares Outstanding:1,370,109Institutional Ownership Pct.:2.59%

Earnings Market Reaction:

Filing Date:2026-05-08Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

ADIAL PHARMACEUTICALS, INC. (ADIL) — SEC Financial Statements & Analysis

ADIAL PHARMACEUTICALS, INC. (ADIL) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2023-12-31	2023-09-30	2023-06-30
Related Party	-	-	0	-0	0	0	-0	0	0	0	-
Accounts Receivable From Securitization	-	-	-	-	-	-	-	-	-	0	1
Assets
Cash And Cash Equivalents At Carrying Value	5	6	5	6	2	4	5	3	3	0	1
Assets Current
Assets Current	5	6	5	6	3	4	6	4	3	1	2
Prepaid Expense Current	-	-	-	-	-	-	0	0	-	-	-
Prepaid Expense And Other Assets Current	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Net Excluding Goodwill	0	0	0	0	0	0	0	0	0	-	-
Indefinite Lived Intangible Assets Excluding Goodw…	-	-	-	-	-	-	-	-	0	0	0
Equity Method Investments	0	0	1	1	1	1	1	1	2	2	2
Assets	5	7	6	7	3	5	7	5	5	3	4
Liabilities And Stockhold…
Accounts Payable Current	1	1	1	1	1	0	0	0	0	0	0
Accrued Liabilities Current	1	1	1	1	1	1	1	0	0	0	0
Liabilities Current
Liabilities Current	2	1	1	1	1	1	1	1	1	1	0
Accrued Liabilities And Other Liabilities	-	-	-	-	-	-	-	-	-	0	0
Other Liabilities Current	-	-	-	-	-	-	-	-	-	0	0
Liabilities	2	1	1	1	1	1	1	1	1	1	0
Long Term Debt And Capita…
Stockholders Equity
Stockholders Equity	4	5	5	6	2	4	6	4	4	2	3
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	96	95	92	92	86	86	86	82	73	69	69
Retained Earnings Accumulated Deficit	-92	-90	-88	-86	-84	-82	-80	-78	-69	-67	-65
Liabilities And Stockholders Equity	5	7	6	7	3	5	7	5	5	3	4
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	100	100	100	8,500	8,500	8,500	8,500	8,500	8,500	8,500	8,500
Common Stock Shares Issued	2	1	1	1	1	0	0	0	0	0	0
Shares Outstanding	2	1	1	1	1	1	1	1	0	0	1

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	67.83%	79.02%	-	-	-	-	-	-	-	-	-	-
2025	-12.31%	-49.23%	-29.23%	-12.50%	0.00%	-12.50%	-3.12%	-25.00%	-34.38%	-16.75%	-19.80%	5.58%
2024	-	-	-	3.09%	0.00%	4.12%	21.21%	10.10%	-16.16%	-10.67%	-8.00%	-8.00%
2023	-6.67%	-30.00%	-10.00%	-12.54%	-17.31%	-35.52%	-6.02%	-18.98%	-48.15%	30.89%	1.63%	-8.94%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	3.18	4.42	4.34	5.02	1.99	4.16	6.78	5.69	4.90	2.15	4.43
Quick Ratio	3.04	4.21	3.99	4.88	1.79	3.84	6.77	5.17	4.33	1.26	4.23
Working Capital	3.29M	4.78M	3.86M	4.87M	1.30M	3.08M	4.79M	3.15M	2.55M	607.31K	1.59M
Leverage & Debt
Debt to Equity	0.41	0.26	0.26	0.22	0.62	0.24	0.14	0.16	0.16	0.23	0.14
Debt Ratio	0.29	0.21	0.20	0.18	0.38	0.19	0.12	0.14	0.14	0.18	0.12
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-5.67	-5.97	-10.81	-0.27	-0.29	-0.30	-0.16	-0.09	-0.10	-0.12	-0.17
Free Cash Flow Per Share TTM	-4.76	-4.86	-4.93	-9.93	-6.31	-8.15	-8.07	-272.81	-225.06	-248.42	-321.98
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-49.63%	-47.23%	82.62%	219.23%	201.10%	149.07%	2.07%	-63.27%	-59.76%	-61.33%	-53.89%
EPS Growth (1Y)	-50.45%	-60.55%	36.19%	-85.15%	-93.24%	-92.64%	-97.04%	999.63%	1,044.13%	1,057.09%	1,226.21%
Valuation Metrics
P/E TTM	-0.32	-0.92	-0.81	-0.33	-1.38	-1.67	-3.15	-0.19	-0.27	-0.34	-0.49
P/B	0.66	1.39	2.61	0.88	9.98	6.20	4.26	0.20	0.34	0.88	1.15
Market Cap	2.45M	7.35M	11.76M	4.89M	21.22M	25.24M	25.05M	872.83K	1.41M	2.05M	3.81M
Enterprise Value	-2.13M	1.47M	7.15M	-1.02M	18.86M	21.49M	19.85M	-2.42M	-1.42M	1.74M	2.59M
Calculated Values
Free Cash Flow TTM	-6.52M	-6.49M	-6.62M	-6.48M	-8.51M	-8.14M	-8.08M	-8.28M	-6.81M	-7.34M	-9.35M
Net Debt	-4.58M	-5.88M	-4.61M	-5.91M	-2.37M	-3.75M	-5.20M	-3.29M	-2.83M	-315.88K	-1.22M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2023-09-29Purchase

Owner: Schuyler, Kevin

Title: -

Shares: 700

Price/Share: $2.74

Value: $1,918.00

Shares Owned: 700

Relationship: Director

Ownership: Direct

2021-12-30Purchase

Owner: Newman, James W. Jr.

Title: -

Shares: 10,000

Price/Share: $2.66

Value: $26,600.00

Shares Owned: 20,000

Relationship: Director

Ownership: Direct

2021-11-30Purchase

Owner: Stilley, William B. Iii

Title: Chief Executive Officer

Shares: 10,600

Price/Share: $2.75

Value: $29,150.00

Shares Owned: 937,646

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2021-11-26Purchase

Owner: Newman, James W. Jr.

Title: -

Shares: 10,000

Price/Share: $2.85

Value: $28,500.00

Shares Owned: 34,475

Relationship: Director

Ownership: Indirect

2021-10-04Sale

Owner: Johnson, Bankole A.

Title: Chief Medical Officer

Shares: 200,000

Price/Share: -

Value: -

Shares Owned: 148,246

Relationship: Officer

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2023-09-29	Schuyler, Kevin	Director	-	Direct	Purchase	700	2.74	$1,918.00	700	4
2021-12-30	Newman, James W. Jr.	Director	-	Direct	Purchase	10,000	2.66	$26,600.00	20,000	4
2021-11-30	Stilley, William B. Iii	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	10,600	2.75	$29,150.00	937,646	4
2021-11-26	Newman, James W. Jr.	Director	-	Indirect	Purchase	10,000	2.85	$28,500.00	34,475	4
2021-10-04	Johnson, Bankole A.	Officer	Chief Medical Officer	Indirect	Sale	200,000	-	-	148,246	4
2021-04-06	Johnson, Bankole A.	Officer	Chief Medical Officer	Indirect	Sale	150,000	2.50	$375,000.00	548,336	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

2.59%

Inst. Shares: 35,546

Shares Outstanding: 1,370,109

2025-12-31

259.67%

Inst. Shares: 3,472,457

Shares Outstanding: 1,337,260

2025-09-30

44.42%

Inst. Shares: 596,900

Shares Outstanding: 1,343,716

2025-06-30

48.00%

Inst. Shares: 646,896

Shares Outstanding: 1,347,585

2025-03-31

46.36%

Inst. Shares: 624,759

Shares Outstanding: 1,347,585

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	35,546	1,370,109	2.59%
2025-12-31	3,472,457	1,337,260	259.67%
2025-09-30	596,900	1,343,716	44.42%
2025-06-30	646,896	1,347,585	48.00%
2025-03-31	624,759	1,347,585	46.36%
2024-12-31	788,109	999,698	78.83%
2024-09-30	582,159	1,002,087	58.09%
2024-06-30	763,374	1,002,087	76.18%
2024-03-31	68,791	30,244	227.45%
2023-12-31	2,893,176	30,244	-
2023-09-30	56,934	29,527	192.82%
2023-06-30	2,120,187	908,850	233.28%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

ADIAL PHARMACEUTICALS, INC. (ADIL) — SEC Financial Statements & Analysis

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.